Reichenbach ZW - Search Results

1

Clinical and translational advances in esophageal squamous cell carcinoma.

Reichenbach ZW, Murray MG, Saxena R, Farkas D, Karassik EG, Klochkova A, Patel K, Tice C, Hall TM, Gang J, Parkman HP, Ward SJ, Tétreault MP, Whelan KA. Reichenbach ZW, et al. Adv Cancer Res. 2019;144:95-135. doi: 10.1016/bs.acr.2019.05.004. Epub 2019 Jun 10. Adv Cancer Res. 2019. PMID: 31349905 Review.

2

Botulinum Toxin A Improves Symptoms of Gastroparesis.

Reichenbach ZW, Stanek S, Patel S, Ward SJ, Malik Z, Parkman HP, Schey R. Reichenbach ZW, et al. Dig Dis Sci. 2020 May;65(5):1396-1404. doi: 10.1007/s10620-019-05885-z. Epub 2019 Oct 15. Dig Dis Sci. 2020. PMID: 31617132 Clinical Trial.

3

The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.

Reichenbach ZW, Li H, Ward SJ, Tuma RF. Reichenbach ZW, et al. Neurosci Lett. 2016 Sep 6;630:9-15. doi: 10.1016/j.neulet.2016.07.041. Epub 2016 Jul 21. Neurosci Lett. 2016. PMID: 27453059 Free PMC article.

4

Cannabinoids and GI Disorders: Endogenous and Exogenous.

Reichenbach ZW, Schey R. Reichenbach ZW, et al. Curr Treat Options Gastroenterol. 2016 Dec;14(4):461-477. doi: 10.1007/s11938-016-0111-1. Curr Treat Options Gastroenterol. 2016. PMID: 27699625 Review.

5

Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.

Nadpara N, Reichenbach ZW, Ehrlich AC, Friedenberg F. Nadpara N, et al. Among authors: reichenbach zw. Dig Dis Sci. 2020 Oct;65(10):2769-2779. doi: 10.1007/s10620-020-06471-4. Dig Dis Sci. 2020. PMID: 32661765 Review.

6

Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.

Selby A, Reichenbach ZW, Piech G, Friedenberg FK. Selby A, et al. Among authors: reichenbach zw. Dig Dis Sci. 2019 Dec;64(12):3385-3393. doi: 10.1007/s10620-019-05846-6. Dig Dis Sci. 2019. PMID: 31541370 Review. No abstract available.

7

Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia.

Ward SJ, Castelli F, Reichenbach ZW, Tuma RF. Ward SJ, et al. Among authors: reichenbach zw. Life Sci. 2018 Feb 15;195:1-5. doi: 10.1016/j.lfs.2017.12.030. Epub 2017 Dec 27. Life Sci. 2018. PMID: 29288767 Free PMC article.

8

A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial.

Reichenbach ZW, Sloan J, Rizvi-Toner A, Bayman L, Valestin J, Schey R. Reichenbach ZW, et al. Clin Ther. 2015 Oct 1;37(10):2267-74. doi: 10.1016/j.clinthera.2015.07.023. Epub 2015 Aug 14. Clin Ther. 2015. PMID: 26283236 Clinical Trial.

9

Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice.

Neelakantan H, Tallarida RJ, Reichenbach ZW, Tuma RF, Ward SJ, Walker EA. Neelakantan H, et al. Among authors: reichenbach zw. Behav Pharmacol. 2015 Apr;26(3):304-14. doi: 10.1097/FBP.0000000000000119. Behav Pharmacol. 2015. PMID: 25485642

10

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.

Reichenbach ZW, DiMattio K, Rajakaruna S, Ambrose D, Cornwell WD, Tallarida RJ, Rogers T, Liu-Chen LY, Tuma RF, Ward SJ. Reichenbach ZW, et al. Front Pharmacol. 2022 Apr 21;13:803331. doi: 10.3389/fphar.2022.803331. eCollection 2022. Front Pharmacol. 2022. PMID: 35529434 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page